Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Nippon Express (Belgium) Acquires GDP Certification for Facility in Brussels Airport's Cargo Area 2022-01-20 15:00
Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine 2022-01-20 07:29
Neurophth Therapeutics Receives IND Clearance to Initiate Clinical Trial for China AAV-ND4 Gene Therapy NR082 in Leber Hereditary Optic Neuropathy 2022-01-19 22:30
Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated Tablets 2022-01-19 20:30
Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings 2022-01-19 19:49
ImmVira's MVR-T3011 IV completed first 2 cohorts dose-escalation of U.S. Phase I clinical study with favorable safety data 2022-01-19 08:30
CN Energy Signs Operation & Management Agreement; Enters Multi-Billion Dollar Pharmaceutical Excipients Market 2022-01-18 21:00
Akeso's AK117 (CD47 monoclonal antibody) in Combination with AK112 (PD-1/VEGF bi-specific antibody) to Initiate a Phase Ib/II Clinical Trial with or without Chemotherapy for the Treatment of Advanced Malignant Tumors 2022-01-18 20:44
MindRank Begins IND-enabling Studies of its first AI-designed Drug, 8 Months After Program Initiation 2022-01-18 17:17
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility 2022-01-18 10:50
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules 2022-01-18 10:41
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation 2022-01-17 21:50
Jacobio Receives IND Approval for Aurora A Inhibitor JAB-2485 from FDA 2022-01-17 09:04
Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference 2022-01-13 08:52
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 2022-01-13 00:00
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors 2022-01-12 21:00
Gracell Biotechnologies Unveils Innovation Center in U.S. 2022-01-12 21:00
Ascentage Pharma Presented at the 40th Annual J.P. Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma 2022-01-12 10:19
Shanghai ZhenGe Biotech Raises USD 100 million Round C Led by Goldman Sachs Asset Management and Sofina 2022-01-11 22:15
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct 2022-01-11 05:30
1 90 91 92 93 94 222